Dare Bioscience Inc (DARE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $12.93M
Last updated: Nov 17, 2026 at 4:33 PM ET
Dare Bioscience Inc (DARE) Stock Chart
Dare Bioscience (DARE) has a latest price of $0.43 on Nov 17, 2026. Its price fell 76.9% over the past 12 months. The month-end price fell 99.3% over the 10 years through Oct 2026, a compound annual decline of 38.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $157.26 in Feb 2017 and its lowest $0.70 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DARE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DARE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 48.0%, and over 6 months it fell 80.9%. The month-end price fell 86.4% over the 3 years through Oct 2026, a compound annual decline of 48.6%.
| Period | Change |
|---|---|
| 1 month | -39.2% |
| 3 months | -48.0% |
| 6 months | -80.9% |
| 12 months | -76.9% |
| 12 months, with dividends | -76.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -86.4% | -48.6% |
| 5 years | -96.0% | -47.5% |
| 10 years | -99.3% | -38.9% |
Price by Year
Its best calendar year was 2020, when the price rose 63.4%, and its weakest was 2017, when it fell 69.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.70 | -63.8% |
| 2025 | $1.93 | -38.1% |
| 2024 | $3.12 | -15.9% |
| 2023 | $3.71 | -62.8% |
| 2022 | $9.96 | -58.5% |
| 2021 | $24.01 | +49.3% |
| 2020 | $16.09 | +63.4% |
| 2019 | $9.84 | +15.4% |
| 2018 | $8.53 | -67.2% |
| 2017 | $25.98 | -69.4% |
Trading Range
The price is 40.4% below its 50-day average of $0.72 and 71.5% below its 200-day average of $1.50.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.43 | |
| 50-day average | $0.72 | -40.4% |
| 200-day average | $1.50 | -71.5% |
Price Risk
Over 3 years, its largest fall from a peak was 94.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.44 |
| Largest fall, 1 year | -86.9% |
| Largest fall, 3 years | -94.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DARE
What is DARE's 1-year price change?
Dare Bioscience's price fell 76.9% over the past 12 months. With dividends included, the 12-month total return was -76.9%.
What is DARE's 5-year price change?
Dare Bioscience's month-end price fell 96.0% over the 5 years through Oct 2026, a compound annual decline of 47.5%. These figures leave out dividends.
What is DARE's beta?
Dare Bioscience's 1-year beta against the S&P 500 is 1.44, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 86.9%.
Is the DARE chart free?
Yes. Advanced Charting for DARE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DARE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors